References
- Burns MJ, Linden CH, Graudins A, Brown RM, Fletcher KE. A comparison of physostigmine and benzodiazepines for the treatment of anticholinergic poisoning. Annals of Emergency Medicine. 2000; 35: 374–381
- Leak D, Carroll D. Promethazine poisoning: Clinical and electroencephalographic observations. British Medical Journal. 1967; 2: 31–32
- Richmond M, Seger D. Central anticholinergic syndrome in a child: A case report. The Journal of Emergency Medicine. 1985; 3: 453–456
- Baehr G, Romano M, Young J. An unusual case of cyproheptadine (Periactin) overdaose in an adolescent female. Paediatric Emergency Care. 1985; 2: 183–185
- Blaustein B., Gaeta T., Balentine J., Gindi M. Cyproheptadine-induced central anticholinergic syndrome in a child: A case report. Paediatric Emergency Care. 1995; 11: 235–237
- Nakamura K, Yokoi T, Inoue K, Shimada N, et al. CYP2D6 is the principal cytochrome P450 responsible for metabolism of the histamine H1 antagonist promethazine in human liver microsomes. Pharmacogenetics. 1996; 6: 449–457
- Spigset O, Granberg K, Hagg S, Norstrom A, Dahlqvist R. Relationship between fluvoxamine pharmacokinetics and CYP2D6/CYP2C10 phenotype polymorphisms. European Journal of Clinical Pharmacology. 1997; 52: 129–133
- D'Arrigo C, Migliardi G, Santoro V, Morgante L, et al. Effect of fluvoxamine on plasma risperidone concentrations in patients with schizophrenia. Pharmacological Research. 2005; 52: 497–501
- Skrobik YK, Bergeron N, Dumont M, Gottfried SB. Olanzapine vs haloperidol: treating delirium in a critical care setting. Intensive Care Medicine. 2004; 30: 444–449
- Bymaster FP, Calligaro DO, Falcone JF, Marsh RD, et al. Radioreceptor binding profile of the atypical antipsychotic olanzapine. Neuropsychopharmacology. 1996; 14: 87–96
- Lim C, Trevino C, Tampi R. Can olanzapine cause delirium in the elderly?. Annals of Pharmacotherapy. 2006; 40: 135–138
- Kubo N, Shirakawa O, Kuno T, Tanaka C. Antimuscarinic effects of antihistamines: quantitative evaluation by receptor binding assay. Japanese Journal of Pharmacology. 1987; 43: 277–282
- Molimard M, Diquet B, Benedetti MS. Comparison of pharmacokinetics and metabolism of desloratadine, fexofenadine, levocetirizine and mizolastine in humans. Fundamental and Clinical Pharmacology. 2004; 18: 399–411
- Beaver KM, Gavin TJ. Treatment of acute anticholinergic poisoning with physostigmine. The American Journal of Emergency Medicine. 1998; 16: 505–507
- Katz R, Rosenthal M. Adverse interaction of cyproheptadine with serotonergic antidepressants. Journal of Clinical Psychiatry. 1994; 55: 314–315
- Duvoisin RC, Katz R. Reversal of central anticholinergic syndrome in man by physostigmine. Journal of the American Medical Association. 1968; 206: 1963
- Cleghorn G, Bourke G. Physostigmine for Promethazine poisoning. The Lancet. 1980; 316: 368–369
- Stewart G. Convulsions after physostigmine. Anaesthesia and Intensive Care. 1979; 7: 283
- Pentel P, Peterson C. Asystole complicating physostigmine treatment of tricyclic antidepressant overdose. Annals of Emergency Medicine. 1980; 9: 588–590
- Noyan M, Elbi H, Aksu H. Donepezil for anticholinergic drug intoxication: A case report. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 2003; 27: 885–887